Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Summary.

ABSTRACT: of recommendations from ASCO and the American Urological Association regarding the chemoprevention of prostate cancer and use of 5-α-reductase inhibitors.

SUBMITTER:  

PROVIDER: S-EPMC2790690 | biostudies-literature | 2009 May

REPOSITORIES: biostudies-literature